
|Articles|February 1, 2000
The American Journal of Managed Care
- February 2000
- Volume 6
- Issue 2
Cost-Effectiveness Analysis under Managed Care: Not Yet Ready for Prime Time?
Advertisement
Articles in this issue
almost 26 years ago
Barriers to Using Cost-Effectiveness Analysis in Managed Cae Decision Makingalmost 26 years ago
Cost of Treating Influenza in Emergency Department and Hospital Settingsalmost 26 years ago
Ischemic Stroke: Acute Management and Secondary Preventionalmost 26 years ago
Is Cost-Effectiveness Modeling Useful?Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Mirvetuximab Soravtansine Demonstrates Promising Efficacy, Safety in Platinum-Resistant Recurrent Ovarian Cancer
2
How Artificial Intelligence Is Transforming Leukemia Detection and Diagnosis
3
Zanubrutinib Shows Similar Efficacy but Better Safety Than VEN–I in Frontline CLL
4
Ocrelizumab Leads to Lower Hospitalization Rates Compared to Rituximab in MS
5














































